NDC 69543-268 - Virt-Phos 250 Neutral
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 69543-268
- Package NDCs from labels
- 69543-268-10
- Manufacturer
- Virtus Pharmaceuticals
- Effective date
- 2022-08-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Virt-Phos 250 Neutral - Virtus Pharmaceuticals | Virtus Pharmaceuticals | 2022-08-19 | DIETARY SUPPLEMENT |
| Av-Phos 250 Neutral Tablets | AvKARE, Inc. | 2016-04-11 | DIETARY SUPPLEMENT |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 69543-268-10 | EA - Each | 69543-268 | 79df6060-26ec-4069-8f3a-6ccddc17ad2c | 1 | 2015-10-02 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| HERA SILKYSTAY FOUNDATION 49C1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f4380d1-2cf4-1fd8-e063-6394a90a0aa3 | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA BLACK CUSHION FOUNDATION 13N1 | OCTINOXATE, TITANIUM DIOXIDE, AND ZINC OXIDE | Amorepacific Corporation | 5aff3d25-d034-0815-e063-6294a90a8664 | 2026-10-29 | Warnings | 15FIX9V2JP |
| Blue Lizard Sensitive SPF 50 Sunscreen | TITANIUM DIOXIDE AND ZINC OXIDE | Crown Laboratories | 32d78048-d281-1d80-e063-6394a90aec19 | 2026-10-28 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 32W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eed2165-afc2-6958-e063-6294a90add58 | 2026-10-28 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 34O1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eedd87b-a7b1-1abc-e063-6294a90ae29e | 2026-10-28 | Warnings | 15FIX9V2JP |
| URIMAR-T CAPS | METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, PHENYL SALICYLATE, METHYLENE BLUE, AND HYOSCYAMINE SULFATE | Allegis Pharmaceuticals, LLC | cf7c3d65-11d2-49cd-b207-8ccc6a221fe0 | 2026-10-26 | Warnings, Adverse reactions | 593YOG76RN |
| MB CAPS | METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, PHENYL SALICYLATE, METHYLENE BLUE, AND HYOSCYAMINE SULFATE | Allegis Pharmaceuticals, LLC | 2efeb281-b84b-4750-e063-6394a90a27ee | 2026-10-26 | Warnings, Adverse reactions | 593YOG76RN |
| HERA SILKYSTAY FOUNDATION 26N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec7151e-4f83-4aca-e063-6294a90a9818 | 2026-10-26 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 26W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec7276d-fcaf-65b2-e063-6394a90ac220 | 2026-10-26 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 28C1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec73566-5d67-7153-e063-6394a90aba33 | 2026-10-26 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 28N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec75100-153c-80cd-e063-6294a90a6d51 | 2026-10-26 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 28O1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec77f7a-4621-ac0c-e063-6294a90a3f70 | 2026-10-26 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 29N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec7ab15-9cc1-d53a-e063-6294a90a4111 | 2026-10-26 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 29W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec83b87-08bc-7590-e063-6294a90a0b78 | 2026-10-26 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 31C1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec857a3-7fd1-6461-e063-6394a90aacd7 | 2026-10-26 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 31N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5ec871dc-f74e-765c-e063-6394a90a27a5 | 2026-10-26 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 13N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb19976-6983-3d9e-e063-6394a90a01ee | 2026-10-25 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 17C2 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb338c7-e99c-887d-e063-6394a90a977c | 2026-10-25 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 17N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb363fe-c2b2-9381-e063-6294a90ad038 | 2026-10-25 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 17W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5eb39387-7f6b-ce78-e063-6394a90a15ae | 2026-10-25 | Warnings | 15FIX9V2JP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.